Commonwealth Equity Services’s Guardant Health GH Stock Holding History

Commonwealth Equity Services’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$872K	Sell	5,814 -171	-3%	-$18.6K	﹤0.01%	2809
2026 Q1	$553K	Sell	5,985 -561	-9%	-$56.3K	﹤0.01%	3127
2025 Q4	$669K	Buy	6,546 +354	+6%	+$31.7K	﹤0.01%	2927
2025 Q3	$387K	Sell	6,192 -3,366	-35%	-$183K	﹤0.01%	3398
2025 Q2	$497K	Sell	9,558 -841	-8%	-$37.6K	﹤0.01%	3137
2025 Q1	$443K	Buy	10,399 +813	+8%	+$35.1K	﹤0.01%	3125
2024 Q4	$293K	Buy	+9,586	New	+$270K	﹤0.01%	3416
2024 Q3	–	Sell	-7,652	Closed	-$221K	–	4121
2024 Q2	$221K	Buy	+7,652	New	+$178K	﹤0.01%	3567
2023 Q3	–	Sell	-6,970	Closed	-$250K	–	3869
2023 Q2	$250K	Buy	+6,970	New	+$200K	﹤0.01%	3198
2022 Q4	–	Sell	-5,585	Closed	-$300K	–	3742
2022 Q3	$300K	Sell	5,585 -535	-9%	-$27.5K	﹤0.01%	2831
2022 Q2	$246K	Buy	6,120 +286	+5%	+$14.2K	﹤0.01%	3011
2022 Q1	$386K	Buy	5,834 +318	+6%	+$21.8K	﹤0.01%	2746
2021 Q4	$551K	Buy	5,516 +361	+7%	+$37.3K	﹤0.01%	2448
2021 Q3	$644K	Sell	5,155 -491	-9%	-$58.3K	﹤0.01%	2282
2021 Q2	$701K	Sell	5,646 -276	-5%	-$37.1K	﹤0.01%	2200
2021 Q1	$903K	Buy	5,922 +478	+9%	+$72.2K	﹤0.01%	1882
2020 Q4	$701K	Sell	5,444 -1,810	-25%	-$208K	﹤0.01%	1891
2020 Q3	$810K	Buy	7,254 +686	+10%	+$62.8K	﹤0.01%	1624
2020 Q2	$532K	Buy	6,568 +1,527	+30%	+$123K	﹤0.01%	1839
2020 Q1	$350K	Sell	5,041 -356	-7%	-$27.3K	﹤0.01%	1957
2019 Q4	$421K	Sell	5,397 -354	-6%	-$25.5K	﹤0.01%	2045
2019 Q3	$367K	Sell	5,751 -61	-1%	-$5.37K	﹤0.01%	2066
2019 Q2	$501K	Buy	5,812 +1,883	+48%	+$144K	﹤0.01%	1789
2019 Q1	$301K	Buy	+3,929	New	+$218K	﹤0.01%	2153

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commonwealth Equity Services's GH Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Guardant Health (GH) stake by 2.9% in Q2 2026, selling an estimated $18.6K and leaving 5,814 shares worth $872K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

Commonwealth Equity Services first reported a position in GH in Q1 2019 and has held it in 24 quarters since. The position peaked at $903K in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Commonwealth Equity Services held 5,814 shares of Guardant Health worth $872K as of Q2 2026.
Commonwealth Equity Services sold 171 Guardant Health shares in Q2 2026, an estimated $18.6K.
Guardant Health made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2809 holding.
Commonwealth Equity Services first reported a position in Guardant Health in Q1 2019 and has held it in 24 quarters since.
Commonwealth Equity Services's Guardant Health position peaked at $903K in Q1 2021.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.